Contraception

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reveals shifts in contraceptive preferences, highlighting increased use of natural family planning, declining reliance on hormonal methods, and the need for better access to reliable information.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reported an increase in US young adults seeking permanent contraception methods following the Supreme Court’s Dobbs v Jackson Women's Health Organization decision in 2022, highlighting the need for accessible contraception.

Jason Bell, MD, discusses the impact of living in contraceptive deserts on college-aged women, highlighting the importance of education, access, and support for reproductive health.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.

A new study finds that intrauterine instillation of 2% mepivacaine significantly lowers pain levels during intrauterine device placement.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

With nearly half of short-acting contraceptive users preferring non-traditional sources such as telehealth and over-the-counter options, a recent study highlights evolving patient needs in contraceptive access.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Following the Dobbs v. Jackson ruling, more women are opting for permanent and long-acting contraceptive methods, even in states where abortion access remains protected.

Find out what’s new and what this means for your practice.

In a recent study, similar bone health results were reported between oral contraceptive users with and without prune consumption, as well as nonusers.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.

In a recent study, rates of 12-month or longer contraceptive supply were increased by the implementation of a 12-month contraceptive supply policy.

Following the Supreme Court’s decision to retain mifepristone access in June 2024, health care providers have spoken out about the need to fight for reproductive health care protections on a national and local level.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The US SPR has been updated to help clinicians address specific issues that may arise in patients using certain contraceptive methods.

Combined hormonal contraceptives such as the combined oral contraceptive pill, the patch, and the vaginal ring each have unique considerations for use in patients with obesity.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Following the Supreme Court's Dobbs decision, rates of self-managed abortions have risen significantly, especially among marginalized communities, highlighting growing barriers to accessing legal abortion care.

Kristyn Brandi, MD, MPH, FACOG, discusses the Supreme Court's decision to maintain mifepristone availability and its potential impact on future women's health cases.